Should ZnanyLekarz prioritize expanding its telemedicine services to reach more patients or focus on improving the quality of in-person consultations with existing doctors?

Introduction

The trade-off ZnanyLekarz faces is whether to prioritize expanding telemedicine services to reach more patients or focus on improving the quality of in-person consultations with existing doctors. This decision involves balancing growth and quality, two critical aspects of healthcare service delivery. I'll analyze this trade-off by examining the product ecosystem, potential impacts, key metrics, and experimental approaches to inform a strategic recommendation.

Step 1

Clarifying Questions (3 minutes)

• Based on the current market trends, I'm thinking telemedicine might be a rapidly growing segment. Could you share some insights on the adoption rate of telemedicine services on our platform over the past year?

Why it matters: Helps understand the growth potential and user demand for telemedicine. Expected answer: Significant increase in telemedicine usage, especially post-pandemic. Impact on approach: High growth would favor expanding telemedicine services.

• Considering our business model, I assume we generate revenue from both telemedicine and in-person consultations. What's the current revenue split between these two service types?

Why it matters: Informs the financial impact of prioritizing one service over the other. Expected answer: In-person consultations still generate the majority of revenue. Impact on approach: Would need to carefully balance growth of telemedicine with maintaining in-person consultation quality.

• Looking at user behavior, I'm curious about patient satisfaction rates for telemedicine vs. in-person consultations. Do we have any data on this?

Why it matters: Indicates which service type might need more quality improvements. Expected answer: Slightly lower satisfaction rates for telemedicine due to technology barriers. Impact on approach: Might suggest focusing on improving telemedicine quality before expansion.

• From a technical perspective, I'm wondering about our current telemedicine infrastructure. How scalable is our existing system if we decide to expand?

Why it matters: Determines the feasibility and potential challenges of telemedicine expansion. Expected answer: Current system can handle moderate growth but would need upgrades for significant expansion. Impact on approach: Would influence the timeline and resources required for telemedicine expansion.

• Considering our team capacity, how are our product and engineering resources currently allocated between telemedicine and in-person consultation improvements?

Why it matters: Helps understand the current focus and potential for reallocation. Expected answer: More resources currently dedicated to in-person consultation improvements. Impact on approach: Would inform the feasibility of shifting focus to telemedicine expansion.